Desjardins Global Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.46M | Sell |
6,036
-394
| -6% | -$160K | 0.26% | 80 |
|
|
2023
Q3 | $2.24M | Buy |
6,430
+4,001
| +165% | +$1.39M | 0.24% | 82 |
|
|
2023
Q2 | $855K | Buy |
2,429
+436
| +22% | +$153K | 0.1% | 206 |
|
|
2023
Q1 | $627K | Sell |
1,993
-4,357
| -69% | -$1.37M | 0.08% | 214 |
|
|
2022
Q4 | $1.83M | Sell |
6,350
-423
| -6% | -$122K | 0.29% | 71 |
|
|
2022
Q3 | $1.96M | Sell |
6,773
-1,446
| -18% | -$419K | 0.25% | 80 |
|
|
2022
Q2 | $2.32M | Buy |
8,219
+7,417
| +925% | +$2.09M | 0.3% | 73 |
|
|
2022
Q1 | $209K | Sell |
802
-48
| -6% | -$12.5K | 0.02% | 353 |
|
|
2021
Q4 | $186K | Buy |
+850
| New | +$186K | 0.02% | 370 |
|